| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $134,000 | 5 | 100 |
Sells | $0 | 0 | 0 |
| Elefant Dov | Chief Financial Officer | 1 | $50,000 | 0 | $0 | $50,000 |
| Lee-Sepsick Kathy | Chief Executive Officer | 1 | $50,000 | 0 | $0 | $50,000 |
| Canning John Charles | Chief Operating Officer | 1 | $14,000 | 0 | $0 | $14,000 |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 1 | $10,000 | 0 | $0 | $10,000 |
| Sipos Jeremy Alexander | Chief Technology Officer | 1 | $10,000 | 0 | $0 | $10,000 |
Femasys Inc., a biomedical company established in 2004 and based in Suwanee, Georgia, primarily targets the women's healthcare market within the United States. The firm's innovative product line includes permanent contraceptive solutions such as FemBloc and FemChec, alongside FemaSeed, which is an artificial insemination offering. For diagnostic purposes, Femasys provides FemCerv, a biopsy device utilized for endocervical curettage, and FemEMB, a product candidate intended for endometrial sampling to assist in the detection of uterine cancer. …
Over the last 12 months, insiders at Femasys Inc. have bought $134,000 and sold $0 worth of Femasys Inc. stock.
On average, over the past 5 years, insiders at Femasys Inc. have bought $134,000 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Elefant Dov (Chief Financial Officer) — $50,000. Lee-Sepsick Kathy (Chief Executive Officer) — $50,000. Canning John Charles (Chief Operating Officer) — $14,000.
The last purchase of 15,625 shares for transaction amount of $50,000 was made by Lee-Sepsick Kathy (Chief Executive Officer) on 2026‑08‑07.
| 2026-08-07 | Lee-Sepsick Kathy | Chief Executive Officer | 15,625 0.5641% | $3.20 | $50,000 | -11.65% | ||
| 2026-08-07 | Elefant Dov | Chief Financial Officer | 15,625 0.5641% | $3.20 | $50,000 | -11.65% | ||
| 2026-08-07 | Canning John Charles | Chief Operating Officer | 4,375 0.1579% | $3.20 | $14,000 | -11.65% | ||
| 2026-08-07 | Sipos Jeremy Alexander | Chief Technology Officer | 3,125 0.1128% | $3.20 | $10,000 | -11.65% | ||
| 2026-08-07 | Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 3,125 0.1128% | $3.20 | $10,000 | -11.65% | ||
| 2021-06-23 | Dyett John | 1,000 0.0459% | $9.95 | $9,950 | -61.10% | |||
| 2021-06-22 | Uzialko Edward R | director | 100,000 6.2919% | $13.00 | $1.3M | -58.84% | ||
| 2021-06-22 | Dyett John | 40,000 2.5168% | $13.00 | $520,000 | -58.84% | |||
| 2021-06-22 | Adams John Q JR | director | 40,000 2.5168% | $13.00 | $520,000 | -58.84% | ||
| 2021-06-22 | Larsen Charles | director | 7,000 0.4404% | $13.00 | $91,000 | -58.84% | ||
| 2021-06-18 | Dyett John | 12,500 0.6491% | $12.94 | $161,750 | -65.46% |
| Elefant Dov | Chief Financial Officer | 15625 0.1866% | $21,875.00 | 1 | 0 | |
| Lee-Sepsick Kathy | Chief Executive Officer | 15625 0.1866% | $21,875.00 | 1 | 0 | |
| Canning John Charles | Chief Operating Officer | 4375 0.0522% | $6,125.00 | 1 | 0 | |
| Sipos Jeremy Alexander | Chief Technology Officer | 3125 0.0373% | $4,375.00 | 1 | 0 | |
| Mifek Jeffrey Gerald | Chief Clinical-Medical Affairs | 3125 0.0373% | $4,375.00 | 1 | 0 | |
| Uzialko Edward R | director | 127786 1.5258% | $178,900.40 | 1 | 0 | <0.0001% |
| Dyett John | 114709 1.3697% | $160,592.60 | 3 | 0 | <0.0001% | |
| Adams John Q JR | director | 40000 0.4776% | $56,000.00 | 1 | 0 | <0.0001% |
| Larsen Charles | director | 7000 0.0836% | $9,800.00 | 1 | 0 | <0.0001% |
| Increased Positions | 20 | +55.56% | 6M | +156.43% |
| Decreased Positions | 11 | -30.56% | 169,060 | -4.5% |
| New Positions | 13 | New | 936,041 | New |
| Sold Out Positions | 6 | Sold Out | 114,468 | Sold Out |
| Total Postitions | 45 | +25% | 9M | +151.93% |
| Dauntless Investment Group, Llc | $1,104.00 | 2.89% | 1.73M | -588,235 | -25.35% | 2025-09-30 |
| Vanguard Group Inc | $606.00 | 1.59% | 951,867 | 0 | 0% | 2025-09-30 |
| Geode Capital Management, Llc | $164.00 | 0.43% | 258,228 | +6,834 | +2.72% | 2025-09-30 |
| Clear Creek Financial Management, Llc | $88.00 | 0.23% | 138,903 | -142,918 | -50.71% | 2025-09-30 |
| Blackrock, Inc. | $63.00 | 0.17% | 98,748 | +1,656 | +1.71% | 2025-09-30 |
| Northern Trust Corp | $48.00 | 0.13% | 75,362 | +21,825 | +40.77% | 2025-09-30 |
| State Street Corp | $36.00 | 0.09% | 56,369 | 0 | 0% | 2025-09-30 |
| Osaic Holdings, Inc. | $30.00 | 0.08% | 47,055 | 0 | 0% | 2025-09-30 |
| Nwf Advisory Services Inc. | $30.00 | 0.08% | 47,055 | 0 | 0% | 2025-09-30 |
| Xtx Topco Ltd | $28.00 | 0.07% | 44,118 | +27,096 | +159.18% | 2025-09-30 |